Harvard Health Letter
Are the new migraine medications working?
Are the new migraine medications working? Doctors say three recently approved migraine prevention drugs are helping people have fewer headaches. For people with frequent, debilitating migraine headaches, 2018 brought encouraging news. The FDA approved three new medications — erenumab (Aimovig), fremanezumab (Ajovy), and galcanezumab (Emgality) — the first drugs designed specifically to prevent migraines and reduce their frequency, intensity, and duration.